How fish oil benefit dogs with cancer
Studies show diets including a balanced dose of pure fish oil may help prevent several human cancers such as breast cancer, colon cancer, and lung cancer. But fish oil isn’t just a good preventative supplement, it’s also helpful for those currently suffering from cancer
Slow tumor growth and spread
Several international studies show fish oil slows the rate tumors grow. [i] And it inhibits metastasis – the process of tumors spreading to other parts of the body.[ii] Both of these benefits could significantly improve your dog’s response to cancer treatments.
Maintain body weight and muscle mass
Many times, cancer patients don’t die from the cancer itself, but from the malnutrition and wasting away cancer causes. This is known as cachexia (ca-kek-see-a).
Researchers found when feeding a high fish oil diet to animals with cancer, the animals maintained more of their body weight. And it increased their muscle mass.[iii] As you can imagine, helping your dog maintain his body weight and muscle mass may increase his chance of surviving the dog cancer treatment.
Improve response to chemotherapy
Another study showed adding fish oil to the diet also helps chemotherapy patients respond better to the treatment. The researchers also found a high fish oil diet also protects animals against the toxins from chemotherapy drugs.[iv][v]
Welsch, CW. Cancer Res., 52: 2040s-2048s, 1992.
Rose, DP, Connolly, JM, and Liu, XH. Diet and Breast Cancer (ed. American Institute for Cancer Research), pp83-91, Plenum Press, New York, 1994.
Tisdale, M and Dhesi, JK. Cancer Res., 50: 5022-5026, 1990.
Shao, Y, Pardini, L and Pardini, RS. Cancer Res., 54:6452-6457, 1994.
Shao, Y, Pardini, L and Pardini, RS. Lipids, 30: 1035-1045, 1995.
Is K9 Omega™ right for my dog?
K9 Omega™ is safe for all dog breeds and has no known side effects. This formula is safe for dogs of all ages, pregnant dogs, and nursing dogs. As with any supplement, we suggest discussing the dosage with your veterinarian first.
Guaranteed safe, natural and effective:
- Safe for all breeds and sizes
- Safe to use with other cancer treatments
- Made with 100% USDA Certified Organic materials
- Manufactured in a FDA registered facility
- 100% non GMO
- Created according to the highest pharmaceutical standards
- Absolutely no binders, fillers, flow enhancers or time release agents
- Have no known side-effects
- 100% non-toxic (no risk of overdosing)
- Backed by our full satisfaction guarantee
Fish Oil Warning
The health supporting fish oil recommended here comes from the body oil of fish such as wild salmon, trout, tuna, sardines, menhaden and herring. We do not recommend using fish liver oil (e.g., cod liver oil). Because if a dog takes fish liver oil and is eating a typical commercial dog food, he risks overdosing on vitamins A and D, which can cause serious consequences.
Contains: 60 soft gels – 1000mg each
This supplement was formulated from all cold water fish sources, using oil from salmon, anchovy, herring, sprat and sardines, with natural vitamin E to enhance freshness.
This product contains NO ingredients from China.
Recommended Daily Use:
Each capsule contains 1000 mg of purified fish oil concentrate. These soft gel capsules can be fed directly as treats. Or they may be opened and the oil squeezed out on the dog’s food. Dosage is one capsule daily per 20 pounds of body weight.
Omega-3 Fatty Acids in Boxer Dogs with Arrhythmogenic Right Ventricular Cardiomyopathy
Fish Oil and Chemotherapy: DHA omega-3 may improve chemotherapy outcomes: Study
By Stephen Daniells, 10-Feb-2010
Related topics: Omega-3, Research, Nutritional lipids and oils, Cancer risk reduction, Women’s health
Supplements of the omega-3 fatty acid docosahexaenoic acid (DHA) may improve outcomes for breast cancer patients undergoing chemotherapy, says a new study from France.
A daily dose of 1.8 grams of DHA also produced no adverse effects, according to a new study published in the British Journal of Cancer.
“Our data show for the first time that a dietary intervention targeted on DHA is a feasible approach that has potential to substantially increase survival in metastatic breast cancer patients treated with chemotherapy,” wrote the researchers, led by Dr Philippe Bougnoux from the French Institut National de la Santé Et de la Recherche Médicale (INSERM) U921 in Tours.
Being a phase II clinical trial, the research represents an “incentive to set up a prospective-controlled randomised trial aimed at identifying the place of dietary DHA in breast cancer treatments”, added the researchers.
Every year about 1.3 million women are diagnosed with breast cancer around the world, with just fewer than half a million deaths associated with the disease, according to the American Cancer Society (ACS).
While the incidence of the disease has increased by about 30 per cent over the last 25 years in the west, death rates have declined dur to improved detection and tratments, said the ACS.
The new study, if supported by additional research, suggests that DHA may help improve survival by sensitising tumours to chemotherapy, said Dr Bougnoux and his co-workers.
The Tours-based researchers recruited 25 women with breast cancer to participate in their open-label single-arm phase II study. As part of their anthracycline-based chemotherapy (FEC) regimen women were given additional DHA (1.8 grams per day, DHA-enriched triglyceride oil of algal origin, supplied by Martek Biosciences) for between 2 and 96 months.
After an average of 31 months, Dr Bougnoux and his co-workers found that the overall survival of women was 22 months, and reached 34 months in women with the highest DHA levels in their blood.
“Although the median time to progression (6 months) and overall survival (22 months) in our study were within the frame of published data, it should be stressed that our patient population had a particularly poor prognosis, as 68 per cent had liver metastases in addition to other sites of metastases,” stated the researchers. “The median overall survival of patients having liver metastases was reported to be 14 months.”
Importantly the DHA supplements during chemotherapy were not associated with any adverse side effects, they added.
Source: British Journal of Cancer
Volume 101, Pages 1978–1985, doi:10.1038/sj.bjc.6605441
“Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial”
Authors: P. Bougnoux, N. Hajjaji, M.N. Ferrasson, B. Giraudeau, C. Couet, O. Le Floch